Oncology & Cancer

Why some melanoma patients do not respond to immunotherapy

By harnessing the immune system against cancer, immunotherapies have revolutionized the way some types of cancer are treated. But most patients—across cancer types—do not respond, and in most cases, scientists are at ...

Medical research

New test to help fight deadly melanoma

Researchers from QIMR Berghofer Medical Research Institute have developed a prototype test that can help identify if patients with deadly metastasised melanoma are likely to benefit from immunotherapy.

Oncology & Cancer

Boosting treatments for metastatic melanoma

University of Cincinnati clinician-scientist Soma Sengupta, MD, Ph.D., says that new findings from her and Daniel Pomeranz Krummel's, Ph.D., team might have identified a treatment-boosting drug to enhance effectiveness of ...

Oncology & Cancer

Scientists identify new target for melanoma immunotherapy

QIMR Berghofer research has found a new reason why some melanoma patients do not respond well to immunotherapy—a discovery that could lead to better-tailored treatments for the potentially deadly cancer.

Oncology & Cancer

Blocking tumor signals can hinder cancer's spread

For most people who die of cancer, the spread of the initial tumor is to blame. "Metastasis is what kills most cancer patients," says Serge Fuchs, a professor in Penn's School of Veterinary Medicine. "Yet there are not many, ...

page 1 from 16